09May/20
NIH: Begins Clinical Trial of Antiviral Remdesivir and Baricitinib (Anti-Inflammatory) For COVID-19
“We now have solid data showing that remdesivir diminishes to a modest degree the time to recovery for people hospitalized with COVID-19,” said NIAID Director Anthony S. Fauci, M.D. Source: VT